Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00401674. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov study NCT00019136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
ClinicalTrials.gov study NCT05316181. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00958698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02659384. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Yoga Practice for Breast or Ovarian Cancer Patients
ClinicalTrials.gov study NCT02305498. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
ClinicalTrials.gov study NCT03393884. IPD Sharing: NO. Countries: 2. Publications: 1.
Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT07100288. IPD Sharing: NO. Countries: 1. Publications: 3.
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00317434. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
ClinicalTrials.gov study NCT01970722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03587129. IPD Sharing: NO. Countries: 1. Publications: 15.
Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01164995. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00563836. IPD Sharing: Not stated. Countries: 2. Publications: 6.
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially
ClinicalTrials.gov study NCT01739218. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer
ClinicalTrials.gov study NCT01253681. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
ClinicalTrials.gov study NCT05872204. IPD Sharing: NO. Countries: 3. Publications: 1.
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
ClinicalTrials.gov study NCT00262990. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
ClinicalTrials.gov study NCT03353831. IPD Sharing: NO. Countries: 12. Publications: 2.
Risk of Ovarian Cancer in Patients With a Pelvic Mass
ClinicalTrials.gov study NCT00315692. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
ClinicalTrials.gov study NCT00484432. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.